Supplements & Compounds
The Antioxidant Paradox: When NRF2 Activation Helps Tumors, Not You
The same cellular switch that supplement brands sell as 'longevity insurance' may quietly favor lung tumors. A new GeroScience analysis forces a harder look at sulforaphane, curcumin, and the broader NRF2 boom.